Who is sponsoring NCT04310267?

NCT04310267 is sponsored by Al-Azhar University.

What drugs are being tested in NCT04310267?

Interventions in NCT04310267: Petit typeface mask.

What condition does NCT04310267 study?

NCT04310267 studies Skeletal Class 3 Malocclusion Due to Maxillary Deficiency.

Is NCT04310267 still recruiting?

NCT04310267 is currently completed. Last updated 21 July 2023.

Last reviewed 2023-07-21 · How we verify

NCT04310267: MaxiProtr

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Three Levels of Force Application for Maxillary Protraction

Completed NA Last updated 21 July 2023

What this trial tests

NA trial testing Petit typeface mask in Skeletal Class 3 Malocclusion Due to Maxillary Deficiency in 30 participants. Completed in 14 March 2022.

Timeline

5 June 2020

Primary endpoint
20 August 2021

14 March 2022

Quick facts

Lead sponsor	Al-Azhar University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	30
Start date	5 June 2020
Primary completion	20 August 2021
Estimated completion	14 March 2022
Sites	1 location across Egypt

Drugs / interventions tested

Petit typeface mask

Conditions studied

Skeletal Class 3 Malocclusion Due to Maxillary Deficiency — all drugs for Skeletal Class 3 Malocclusion Due to Maxillary Deficiency →

Sponsor

Al-Azhar University

Who can join

Adults 7 to 10, any sex, with Skeletal Class 3 Malocclusion Due to Maxillary Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate dentoskeletal changes concomitant with different three levels of force application for maxillary protraction in growing patients with skeletal class 3 malocclusion.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Orthodontic treatment for prominent lower front teeth (Class III malocclusion) in children.
Owens D, Watkinson S, Harrison JE, Turner S, et al · · 2024 · cited 10× · PMID 38597341 · DOI 10.1002/14651858.cd003451.pub3

Verify or expand the search:

Other Al-Azhar University trials

Trials by the same sponsor.

NCT06489327 — Comparing Two Doses of Oral Melatonin as Premedication in Children Undergoing Surgery · NA · recruiting
NCT07327918 — Effect of Epidural Needle Injection on Catheter Placement Success During Painless Labour · Phase 3 · not yet recruiting
NCT07500194 — Quad Helix vs RME for Posterior Cross-bite in Egyptian Children · NA · not yet recruiting
NCT07360756 — Ultrasonographic ONSD as a Predictor of PDPH in Spinal Anesthesia for Cesarean Delivery · not yet recruiting
NCT07343570 — Comparison of Quadratus Lumborum and Combined Groin Nerve Blocks for Postoperative Analgesia After Open Inguinal Hernia · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04310267 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Al-Azhar University
Last refreshed: 21 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04310267.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing